首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1490048

经皮皮肤贴片市场：按类型、按应用、按分销管道、按地区

Transdermal Skin Patches Market, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月17日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球经皮皮肤贴片市场规模为87.9亿美元，预计到2031年将达到128.2亿美元，2024年至2031年复合年增长率为5.5%。

报告范围		报告详情
基准年	2023年	2024年市场规模	87.9亿美元
实际资料	2019年至2023年	预测期	从2024年到2031年
预测 2024-2031 年复合年增长率：	5.50%	2031年价值预测	128.2亿美元

图：2024 年按地区分類的经皮皮肤贴片市场占有率(%)

近年来，由于各种慢性疾病的全球盛行率不断增加，经皮皮肤贴片的全球市场受到关注。经皮皮肤贴片提供了便捷的药物传递方式，与传统的药物传递方法相比具有多种优点。这些贴片以预定的速率和预定的时间将药物通过皮肤输送到血液中。口服给药可最大程度地减少胃刺激并允许药物长时间释放。此外，经皮皮肤贴片提供非侵入性、无痛的药物输送，提高患者对治疗的遵从性。老年人口的增加、自我给药需求的增加以及对方便的药物输送系统的需求不断增长是预计未来几年推动经皮皮肤贴片需求的一些主要因素。

市场动态：

心血管疾病、糖尿病、慢性疼痛、癌症和神经病变等慢性疾病的盛行率不断上升，是推动全球采用经皮皮肤贴片的主要因素。此外，老年人口的增加也推动了市场的成长，老年人口更容易罹患慢性病。由于非侵入性、无针给药系统方便易用，患者和看护者越来越偏好这种系统，这进一步推动了对经皮皮肤贴片的需求。另一方面，与基于经皮皮肤贴片的药物输送系统相关的高开发成本以及与临床试验相关的监管挑战是预计在预测期内在一定程度上抑制市场成长的一些因素。然而，配方技术的进步正在提高更广泛的药物传输速度。预计这将为市场参与者提供利润丰厚的成长机会。

本研究的主要特点

该报告对全球经皮皮肤贴片市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
我们根据以下参数对全球经皮皮肤贴片市场的主要企业进行了介绍——公司亮点、产品系列、主要亮点、财务表现和策略。
主要公司包括Novartis AG、Purdue Pharma LP、Viatris, Inc.、Teikoku Pharma USA, Inc.、Johnson &Johnson Services, Inc.、Teva Pharmaceutical Industries Ltd.、LUYE PHARMA AG、Samyang Holdings Corporation、Vektor Pharma、Hisamitsu Pharmaceutical Co. 。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球经皮皮肤贴片市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球经皮皮肤贴片市场的各种策略矩阵来促进他们的决策。

公司简介
- Novartis AG
- Purdue Pharma LP
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson &Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB SA
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

第10章分析师观点

Wheel of Fortune
分析师观点
Coherent Opportunity Map

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI5085

The global transdermal skin patches market is estimated to be valued at USD 8.79 Bn in 2024 and is expected to reach USD 12.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 8.79 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	5.50%	2031 Value Projection:	US$ 12.82 Bn

Figure. Transdermal Skin Patches Market Share (%), By Region, 2024

The global transdermal skin patches market has been gaining traction over the past few years owing to the growing prevalence of various chronic diseases globally. Transdermal skin patches provide a convenient mode of delivery of drugs and offer several advantages over conventional drug delivery methods. These patches administer medication through the skin and into the bloodstream at a predetermined rate for an intended duration. They minimize gastric irritation caused by oral administration of drugs and provide controlled release of drug for an extended period of time. Moreover, transdermal skin patches offer non-invasive and painless delivery of drugs, which enhances patient compliance in therapy. Rising geriatric population, increasing demand for self-administration of drugs, and growing need for convenient drug delivery systems are some of the key factors anticipated to fuel the demand for transdermal skin patches in the coming years.

Market Dynamics:

Growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, chronic pain, cancer, and neurological disorders, is a key factor boosting the adoption of transdermal skin patches globally. Moreover, the rising geriatric population who are more prone to develop chronic conditions is also augmenting the market growth. The growing preference of patients and care-givers for non-invasive and needle-free drug delivery systems owing to convenience and ease-of-use is further propelling the demand for transdermal skin patches. On the other hand, high development costs associated with transdermal patch-based drug delivery systems and regulatory challenges pertaining to clinical trials are some of the factors expected to restrain the market growth to a certain extent over the forecast period. However, ongoing advancements in formulation technologies are aimed at enhancing delivery rates of a wider range of drugs. This is expected to offer lucrative growth opportunities for players in this market.

Key Features of the Study:

This report provides an in-depth analysis of the global transdermal skin patches market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global transdermal skin patches market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Novartis AG, Purdue Pharma L.P., Viatris, Inc., Teikoku Pharma USA, Inc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., LUYE PHARMA AG, Samyang Holdings Corporation, Vektor Pharma, Hisamitsu Pharmaceutical Co.,Inc., UCB S.A., Hikma Pharmaceuticals PLC , Corium, Inc., Nitto Denko Corporation, Gedeon Richter Plc., Agile Therapeutics, Amneal Pharmaceuticals LLC., Cipla, and AdhexPharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global transdermal skin patches market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transdermal skin patches market.

Detailed Segmentation-

By Type:
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
By Application:
- Pain Relief
- Smoking Cessation
- Overactive Bladder
- Hormonal Therapy
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Purdue Pharma L.P.
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Transdermal Skin Patches Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Transdermal Skin Patches Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Single-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Multi-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Matrix
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Transdermal Skin Patches Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pain Relief
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Smoking Cessation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Overactive Bladder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hormonal Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Transdermal Skin Patches Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Transdermal Skin Patches Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Purdue Pharma L.P.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Viatris, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teikoku Pharma USA, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LUYE PHARMA AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Samyang Holdings Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

10. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

经皮皮肤贴片市场：按类型、按应用、按分销管道、按地区